Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) CFO Steven Cook sold 6,800 shares of Omada Health stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $21.86, for a total transaction of $148,648.00. Following the transaction, the chief financial officer directly owned 173,906 shares in the company, valued at approximately $3,801,585.16. This trade represents a 3.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Omada Health Trading Up 4.3%
NASDAQ:OMDA opened at $20.50 on Tuesday. The firm’s fifty day simple moving average is $22.58 and its 200 day simple moving average is $18.03. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $26.92. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 410.00 and a beta of 1.86.
Omada Health (NASDAQ:OMDA – Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The firm had revenue of $87.83 million during the quarter, compared to the consensus estimate of $80.93 million. On average, analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current year.
Institutional Trading of Omada Health
Analysts Set New Price Targets
Several research firms recently commented on OMDA. JPMorgan Chase & Co. boosted their price target on Omada Health from $26.00 to $30.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Barclays increased their price objective on shares of Omada Health from $25.00 to $27.00 and gave the company an “overweight” rating in a research report on Friday. Weiss Ratings upgraded shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Robert W. Baird boosted their target price on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 12th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $28.00 price target on shares of Omada Health in a report on Friday. Eleven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $26.67.
Read Our Latest Stock Report on Omada Health
Omada Health Company Profile
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.
The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.
Omada primarily serves members through employers, health plans and healthcare organizations in the United States.
See Also
- Five stocks we like better than Omada Health
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
